surmount-1 tirzepatide weight loss percent 72 weeks for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Adults with obesity using tirzepatide

It is intended solely for controlled laboratory research by qualified professionals

Beyond nausea management, B12 supplementation addresses a practical concern

The results from this initial trial, conducted at the University of North Carolina-Chapel Hill School of Medicine and funded by the National Institute on Alcohol Abuse and Alcoholism, are compelling

In this years first quarter, with company supply shortages no longer an issue and the FDA pressing for an end to mass compounding, Hybio, Sinopep and others were still bringing in sizable shipments of ingredients to copy both drugs

Sagging skin is really impossible to avoid when you lose a lot of weight quickly, Szoke says

The study will be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (26 October), by Dr Thomas Karagiannis, Aristotle University of Thessaloniki, Thessaloniki, Greece, and colleagues